Even though the direct evidence of ARHGAP25 playing a relevant role in non-hematopoietic cells during pathophysiological processes is still insufficient, the possibility of it taking part in other pathways might open new avenues for cancer treatment. The gene discussed is ARHGAP25; the disease is cancer.